Spots Global Cancer Trial Database for amifostine
Every month we try and update this database with for amifostine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine | NCT01288625 | Oral Mucositis Stomatitis | Amifostine Amifostine | 18 Years - 70 Years | Sun Pharmaceutical Industries Limited | |
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment | NCT00409331 | Head and Neck C... | Amifostine Intensity- Modu... | 18 Years - | M.D. Anderson Cancer Center | |
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation | NCT00003143 | Lymphoma | Amifostine DHAP | 18 Years - | Jonsson Comprehensive Cancer Center | |
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer | NCT00601198 | Colorectal Canc... | Amifostine | 18 Years - | University of Cincinnati | |
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine | NCT01288625 | Oral Mucositis Stomatitis | Amifostine Amifostine | 18 Years - 70 Years | Sun Pharmaceutical Industries Limited | |
Subcutaneous Amifostine Safety Study | NCT00158041 | Head and Neck C... Lung Cancer Lymphoma | Amifostine admi... | 18 Years - | Mt. Sinai Medical Center, Miami | |
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation | NCT00003143 | Lymphoma | Amifostine DHAP | 18 Years - | Jonsson Comprehensive Cancer Center | |
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | NCT00040365 | Prostatic Neopl... | Amifostine trih... Radiation thera... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors | NCT05167370 | Solid Tumors Brain Tumors | Amifostine | - 30 Years | Children's Hospital Medical Center, Cincinnati | |
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | NCT00274937 | Stage I Nasopha... Stage I Nasopha... Stage II Nasoph... Stage II Nasoph... Stage III Nasop... Stage III Nasop... Stage IV Nasoph... Stage IV Nasoph... | Amifostine Cisplatin Fluorouracil Laboratory Biom... Radiation Thera... | - 18 Years | Children's Oncology Group | |
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy | NCT01998529 | Lung Cancer | Cisplatin Amifostine | 3 Years - 21 Years | M.D. Anderson Cancer Center | |
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors | NCT05167370 | Solid Tumors Brain Tumors | Amifostine | - 30 Years | Children's Hospital Medical Center, Cincinnati | |
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | NCT00081315 | Esophagitis Pneumonitis Non-Small Cell ... | Amifostine | 18 Years - | MedImmune LLC | |
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer | NCT03702985 | Locally Advance... | Radiation Capecitabine Irinotecan Amifostine | 18 Years - 75 Years | Fudan University | |
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | NCT00078845 | Breast Cancer Lung Cancer Neurotoxicity Ovarian Cancer Prostate Cancer Unspecified Adu... | Amifostine | 18 Years - | M.D. Anderson Cancer Center | |
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck | NCT00318890 | Cancer of Head ... Head Cancer Head and Neck C... Neck Cancer Neck Neoplasms | Cisplatin Docetaxel Radiotherapy Amifostine | 19 Years - | University of Alabama at Birmingham | |
Amifostine in Treating Patients With Myelodysplastic Syndrome | NCT00003048 | Myelodysplastic... | Amifostine Trih... | 18 Years - | M.D. Anderson Cancer Center | |
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) | NCT00270790 | Head and Neck C... | Amifostine Carboplatin Taxol Radiotherapy | 18 Years - | University of Maryland, Baltimore | |
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine | NCT01288625 | Oral Mucositis Stomatitis | Amifostine Amifostine | 18 Years - 70 Years | Sun Pharmaceutical Industries Limited | |
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors | NCT05167370 | Solid Tumors Brain Tumors | Amifostine | - 30 Years | Children's Hospital Medical Center, Cincinnati | |
Randomized Amifostine For SCCHN | NCT00095927 | Chemotherapeuti... Head and Neck C... Mucositis Radiation Toxic... Xerostomia | Amifostine Carboplatin Paclitaxel radiation | 18 Years - | Dana-Farber Cancer Institute | |
Determination of Amifostine Levels During Radiation Therapy | NCT00286611 | Cancer | Blood and saliv... | 18 Years - | University of Iowa | |
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity | NCT01586117 | Rectal Cancer | Amifostine | 18 Years - 75 Years | ChineseAMS |